IHE

iShares US Pharmaceuticals ETF
NYSEARCA

Real-time Quotes | Provided by Morningstar

168.11
+0.97
+0.58%
Closed 16:00 10/23 EDT
OPEN
167.69
PREV CLOSE
167.14
HIGH
168.11
LOW
166.90
VOLUME
2.96K
TURNOVER
--
52 WEEK HIGH
172.58
52 WEEK LOW
115.53
TOTAL ASSET
351.13M
YTD YIELD
3.26%
1D
5D
1M
3M
1Y
5Y
News
Performance
Trump vs Biden: Here are the health-care stocks that could benefit from the 2020 election
Health care is again at a political crossroads heading into the U.S. presidential election. Gina Sanchez of Chantico Global and Craig Johnson of Piper Sandler discuss the potential winners and losers in the space.
CNBC.com · 09/28 13:04
Craving Healthcare: A Beginner's Guide And My 7 Picks
Seeking Alpha - Article · 07/31 16:00
FDA to resume on-site inspections in U.S.
Seeking Alpha - Article · 07/10 16:43
Eli Lilly Q1 Earnings Call Key Takeaways
Seeking Alpha - Article · 04/27 11:22
Sanders' big Nevada primary win shakes health-related stocks
Seeking Alpha - Article · 02/24 15:10
Should Investors Avoid U.S. Healthcare Stocks In An Election Year?
Seeking Alpha - Article · 02/10 14:35
Investing In The Prospect Of Drug Pricing Reforms
Seeking Alpha - Article · 02/06 12:29
California mulling private-label generics to address high drug costs
Seeking Alpha - Article · 01/09 15:05
More
No Data
Learn about the latest financial forecast of IHE. Analyze the recent business situations of iShares US Pharmaceuticals ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
08/31/2020
10 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Month
1.9367%
--
3-Month
4.0582%
--
6-Month
12.6868%
--
1-Year
3.2634%
--
3-Year
3.2315%
--
5-Year
1.4765%
--
10-Year
12.4567%
--
Since Inception
10.1687%
--
No Data
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
Profile
Fund Name
iShares US Pharmaceuticals ETF
Risk
Medium-low risk
Inception Date
2006-05-01
Benchmark
Dow Jones US Healthcare TR
Advisor Company
iShares
Custodian
State Street Bank & Trust Co
Manager
Team Managed